Sign in

CIK 0001551306

  • Large accelerated filer

Progyny, Inc.

Sign in to watch
Ticker
PGNY
Exchange
Nasdaq
Industry
Services-Misc Health & Allied Services, NEC
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
272220139
Phone
+1 212-888-3124
Business address
1359 BROADWAY, 2ND FLOOR, NEW YORK, NY, 10018
Former names
Auxogyn, Inc., Auxogyn Inc
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$22,674,844
in 10 filings, $22.0M under 10b5-1 plans

Net −$22,674,844. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-10-24 Dean Lloyd H Director Grant or award · Stock Option (Right to Buy) +584 584
2022-10-24 Cohen Fred E Director Grant or award +3,480 12,132
2022-10-24 Cohen Fred E Director Grant or award · Stock Option (Right to Buy) +15,660 15,660
2022-10-24 Cohen Fred E Director Grant or award · Stock Option (Right to Buy) +1,460 1,460
2022-10-24 HOLSTEIN ROGER C Director Grant or award +2,900 5,110
2022-10-24 HOLSTEIN ROGER C Director Grant or award · Stock Option (Right to Buy) +14,500 14,500
2022-10-24 Scott Cheryl Director Grant or award +2,900 8,110
2022-10-24 Scott Cheryl Director Grant or award · Stock Option (Right to Buy) +14,500 14,500
2022-10-24 GORDON KEVIN K Director Grant or award +2,900 10,110
2022-10-24 GORDON KEVIN K Director Grant or award · Stock Option (Right to Buy) +14,500 14,500
2022-10-24 Park Jeffrey G Director Grant or award +3,480 12,132
2022-10-24 Park Jeffrey G Director Grant or award · Stock Option (Right to Buy) +16,240 16,240
2022-10-24 Park Jeffrey G Director Grant or award · Stock Option (Right to Buy) +1,752 1,752
2022-10-20 Anevski Peter CHIEF EXECUTIVE OFFICER Exercise or conversion +2,248 $3.95 $9K 252,693
2022-10-20 Anevski Peter CHIEF EXECUTIVE OFFICER Sale −2,248 $39.38 $89K 250,445
2022-10-20 Anevski Peter CHIEF EXECUTIVE OFFICER Sale −562 $39.38 $22K 185,575
2022-10-20 Anevski Peter CHIEF EXECUTIVE OFFICER Exercise or conversion · Option (Right to Buy) −2,248 1,471,465
2022-10-20 Schlanger David J Executive Chairman Exercise or conversion +2,200 $0.91 $2K 84,748
2022-10-20 Schlanger David J Executive Chairman Sale −2,200 $39.37 $87K 82,548
2022-10-20 Schlanger David J Executive Chairman Exercise or conversion · Option (Right to Buy) −2,200 1,384,669

Page 39 of 77 · 1,524 trades